Check Screen Reader Mode to make this survey compatible with screen readers.
Check Screen Reader Mode to make this survey compatible with screen readers.

Pharmacy Staff Resource Requirements for New HTA Approved Drugs BOPA Questionnaire

Pharmacy Staff Resource Requirements for New HTA Approved Drugs BOPA Questionnaire

Since 2000, NICE has performed 323 technology appraisals resulting in 387 individual recommendations on cancer drugs. This is a positive approval rate of 75% for cancer drugs.

Since 2011, the SMC has performed 260 technology appraisals resulting in 181 accepted or restricted recommendations on cancer drugs. This is a positive approval rate of 70% for cancer drugs.

The number of cancer technology appraisals has increased dramatically over the last couple of years and this has led to an increasing amount of pressure on the NHS to implement and deliver these innovative new medicines to patients.

A positive technology appraisal for a new drug or an existing drug with a new indication requires pharmacy staff to write a new Systemic Anti-Cancer Trust (SACT) protocol (Note: a SACT protocol could also be known as a prescription pro forma or screening protocol. The information contained could include the following e.g. indication, treatment intent, monitoring parameters, dosing, cycle numbers, dose modification and adverse events). The new SACT protocol will need to be checked for accuracy and built on the Trusts electronic prescribing system by pharmacy staff. Currently individual Trusts undertake this work meaning there is a large amount of duplication and variation across the country.

This questionnaire is looking to quantify the pharmacy resource required across England, Wales, Scotland and NI to undertake this process. As a result of the survey, BOPA will look at ways to help reduce this duplication.
1.What is the name of your Trust/ organisation?
2.Do you work in the NHS or independent sector?
3.What NHS Band or equivalent are you?:
4.What cancer services does your Trust/organisation provide? (Select more than one if applicable)
5.When writing a SACT protocol for a newly approved drug (not previously used) how long does it take to write?
6.When writing a SACT protocol for a newly approved indication for an existing drug how long does it take to write?
7.What band usually writes the new SACT protocols?
8.When checking a newly written SACT protocol for a new drug on average how long would you say this process takes?
9.When checking a newly written SACT protocol for a newly approved indication for an existing drug on average how long would you say this process takes?
10.What band usually checks the new SACT protocols?
11.Are there any other Health Care Professionals involved in checking the SACT protocols
12.How long does it take to build a newly approved drug/ indication for an existing drug on to the Trusts/organisations electronic prescribing system?
13.How long does it take to check a newly approved drug/ indication for an existing drug on the Trusts/organisations electronic prescribing system?
14.Are there any other Health Care Professionals involved in checking the Trust /organisation electronic prescribing system? (Select more than one)
15.When a new drug/line extension has a positive Health Technology Appraisal (HTA) from NICE/SMC (or a new market authorisation in the independent sector) on average how long does it take to be available to prescribe in your Trust/organisation?
16.How likely do you think it is that your Trust/organisation will utilise nationally written and approved protocols?
17.Any other relevant information you would like to include
Current Progress,
0 of 17 answered